System for Electronic Document Analysis and Retrieval

Early Warning News Release of Australis Capital Inc.

Retrieved on: 
Wednesday, May 29, 2019
Corporate finance, Finance, Economy, Money, Options, Warrant, System for Electronic Document Analysis and Retrieval, Debenture

After the Acquisition, Australis holds 34,873,628 Common Shares and Debentures in the principal amount of $1,600,000.

Key Points: 
  • After the Acquisition, Australis holds 34,873,628 Common Shares and Debentures in the principal amount of $1,600,000.
  • Australis paid CAD $6,396,920 to exercise the Warrants at a price of $0.50 per share resulting in 12,793,840 Common Shares.
  • This press release is issued pursuant to early warning requirements of National Instrument 62-104 and National Instrument 62-103, which also requires a report to be filed with regulatory authorities in each ofthe jurisdictions containing additional information with respect to the foregoing matters (the "Early Warning Report").A copy of the Early Warning Report will be available under the Company's SEDAR profile at www.sedar.com .
  • For further information about Australis, please visit the website at ausacap.com or contact the Company by e-mail at [email protected] .

GoldMining Announces Voting Results

Retrieved on: 
Thursday, May 23, 2019
Economy of Canada, System for Electronic Document Analysis and Retrieval, Athabasca Basin, Athabasca, Canada

Detailed voting results for the Meeting are available on SEDAR at www.sedar.com .

Key Points: 
  • Detailed voting results for the Meeting are available on SEDAR at www.sedar.com .
  • GoldMining is a public mineral exploration company focused on the acquisition and development of gold assets in the Americas.
  • Through its disciplined acquisition strategy, GoldMining now controls a diversified portfolio of resource-stage gold and gold-copper projects in Canada, U.S.A., Brazil, Colombia and Peru.
  • Additionally, GoldMining owns a 75% interest in the Rea Uranium Project, located in the Western Athabasca Basin of Alberta, Canada.

Galaxy Digital Announces Material Realized Gain

Retrieved on: 
Tuesday, May 21, 2019
Economy of Canada, System for Electronic Document Analysis and Retrieval, Galaxy Digital

NEW YORK, May 21, 2019 /CNW/ -Galaxy Digital Holdings Ltd. (TSXV: GLXY; Frankfurt: 7LX) ("Galaxy Digital" or the "Company") and Galaxy Digital Holdings LP (the "Partnership") announce an update to Partnership's material investment position.

Key Points: 
  • NEW YORK, May 21, 2019 /CNW/ -Galaxy Digital Holdings Ltd. (TSXV: GLXY; Frankfurt: 7LX) ("Galaxy Digital" or the "Company") and Galaxy Digital Holdings LP (the "Partnership") announce an update to Partnership's material investment position.
  • Galaxy Digital is a diversified, multi-service merchant bank dedicated to the digital assets and blockchain technology industry.
  • Galaxy Digital currently operates four distinct business lines, which include: Trading, Asset Management, Principal Investments and Advisory Services.
  • Information identifying assumptions, risks and uncertainties relating to Galaxy Digital is contained in Galaxy Digital's filings with the Canadian securities regulators available at www.sedar.com .

Spectra7 Announces First Quarter 2019 Financial Results

Retrieved on: 
Wednesday, May 15, 2019
Technology, Data management, Hardware, Internet, Networks, Audio, Video, Semiconductor, Economy of Canada, System for Electronic Document Analysis and Retrieval, Forward-looking statement

(TSX:SEV) Spectra7 Microsystems Inc. (Spectra7 or the Company), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, today announced its unaudited financial results for the three month period ended March 31, 2019.

Key Points: 
  • (TSX:SEV) Spectra7 Microsystems Inc. (Spectra7 or the Company), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, today announced its unaudited financial results for the three month period ended March 31, 2019.
  • A copy of the unaudited consolidated financial statements prepared in accordance with International Financial Reporting Standards and the corresponding managements discussion and analysis (MD&A) for the quarter ended March 31, 2019, can be found under the Companys profile at www.sedar.com .
  • I am pleased with our Q1 performance that we had pre-announced, particularly given that the first quarter is seasonally a slow quarter in our industry.
  • Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements.

The Stars Group Shareholders Approve Resolutions at Shareholder Meeting

Retrieved on: 
Wednesday, May 15, 2019
Articles, Shareholders, Corporate law, Meetings, Economy of Canada, System for Electronic Document Analysis and Retrieval, Annual general meeting, Board of directors, Business, Corporations

Each director will serve until The Stars Group's next annual meeting of shareholders or until their respective successors are elected or appointed or they otherwise cease to hold office.

Key Points: 
  • Each director will serve until The Stars Group's next annual meeting of shareholders or until their respective successors are elected or appointed or they otherwise cease to hold office.
  • The resolutions voted on at the meeting are described in more detail in The Stars Group's Management Information Circular, dated April 12, 2019, which was mailed to shareholders and is available on SEDAR at www.sedar.com and Edgar at www.sec.gov .
  • Service as a director on the Board of Directors of The Stars Group may be subject to gaming or other legal and regulatory approval.
  • The Stars Group is a provider of technology-based product offerings in the global gaming and interactive entertainment industries.

Titan Medical Reports First Quarter 2019 Financial Results

Retrieved on: 
Tuesday, May 14, 2019
Health, Hospitals, Medical devices, Economy of Canada, System for Electronic Document Analysis and Retrieval, International Financial Reporting Standards, Economy, Articles

Titan Medical Inc. (TSX: TMD) (NASDAQ: TMDI) (Titan or the Company), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), announces financial results for the three months ended March 31, 2019.

Key Points: 
  • Titan Medical Inc. (TSX: TMD) (NASDAQ: TMDI) (Titan or the Company), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), announces financial results for the three months ended March 31, 2019.
  • All financial results are prepared in accordance with International Financial Reporting Standards (IFRS) and are reported in U.S. dollars, unless otherwise stated.
  • The unaudited condensed interim financial statements and managements discussion and analysis for the period ended March 31, 2019 may be viewed on SEDAR at www.sedar.com .
  • Financial results for the first quarter of 2019 include:
    Research and development expenses for the first quarter of 2019 were $14,408,612, compared with $3,274,074 for the corresponding prior-year period, as the Company accelerated advanced product development in preparation for planned GLP and IDE studies.

Supreme Cannabis Announces Q3 2019 Financial Results

Retrieved on: 
Monday, May 13, 2019
Cannabis, Cannabis smoking, Entheogens, Euphoriants, System for Electronic Document Analysis and Retrieval, Medicine, Drugs, Psychoactive drugs, Cannabis in Canada

In Q3 2019, Supreme Cannabis' wholly-owned subsidiary, 7ACRES, began supplying high-end cannabis flower to the province of New Brunswick and retailers in Saskatchewan, increasing distribution to eight provinces.

Key Points: 
  • In Q3 2019, Supreme Cannabis' wholly-owned subsidiary, 7ACRES, began supplying high-end cannabis flower to the province of New Brunswick and retailers in Saskatchewan, increasing distribution to eight provinces.
  • Under the terms of this agreement, all cannabis oil products processed by MediPharm will be sold under Supreme Cannabis' brands.
  • Towards the end of Q3 2019, Supreme Cannabis announced the appointment of Mr. Nikhil Handa to Chief Financial Officer.
  • Supreme Cannabis' 2019 third quarter MD&A and consolidated financial statements for the quarter ended March 31, 2019, along with all previous public filings of The Supreme Cannabis Company, Inc. may be found on SEDAR at www.SEDAR.com .

Cipher Pharmaceuticals Reports First Quarter 2019 Financial Results

Retrieved on: 
Friday, May 10, 2019
Economy of Canada, System for Electronic Document Analysis and Retrieval, Cipher, Oakville, Ontario

OAKVILLE, ON, May 10, 2019 /CNW/ -Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three months ended March 31st, 2019.

Key Points: 
  • OAKVILLE, ON, May 10, 2019 /CNW/ -Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three months ended March 31st, 2019.
  • (All figures are in U.S. dollars)
    Total revenue was $5.1 million for Q1 2019 compared to $4.6 million for Q1 2018.
  • Cipher's Financial Statements for the three months ended March 31, 2019 and Management's Discussion and Analysis ("MD&A") for the three months ended March 31, 2019 are available on the Company's website at www.cipherpharma.com in the "Investors" section under "Financial Reports" and on SEDAR at www.sedar.com .
  • Cipher will hold a conference call today, May 10, 2019, at 8:30 a.m. (ET) to discuss its financial results and other corporate developments.

TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders

Retrieved on: 
Wednesday, May 8, 2019
Economy of Canada, System for Electronic Document Analysis and Retrieval, Sterilization, Medical device, Light-emitting diode, Articles, Electromagnetism, Light

Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 7, 2019, will be filed on SEDAR ( www.sedar.com ) under the name TSO3.

Key Points: 
  • Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 7, 2019, will be filed on SEDAR ( www.sedar.com ) under the name TSO3.
  • Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
  • For more information about TSO3, visit the Company's website at www.tso3.com .

InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019

Retrieved on: 
Wednesday, May 8, 2019
Financial statements, Communication, Forward-looking statement, System for Electronic Document Analysis and Retrieval, INMED, Articles

The Company's full financial statements and related MD&A for the three months ended March 31, 2019 will be available at www.sedar.com on May 15, 2019.

Key Points: 
  • The Company's full financial statements and related MD&A for the three months ended March 31, 2019 will be available at www.sedar.com on May 15, 2019.
  • The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines.
  • Cautionary Note Regarding Forward-Looking Information:
    This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws.
  • While InMed considers these assumptions to be reasonable, these assumptions are inherently subject to significant business, economic, competitive, market and social uncertainties and contingencies.